Thermo Fisher Scientific (TMO) Could Be Fully Valued On Parkinsons Proteomics Progress

Thermo Fisher Scientific (TMO) is drawing investor attention after completing Olink Explore HT proteomic analysis on about 5,500 samples from The Michael J. Fox Foundation’s Parkinson’s Precision Medicine Initiative. See our latest analysis for Thermo Fisher Scientific. The proteomics update arrives after a strong run in Thermo Fisher Scientific’s stock, with the share price at US$629.27 and a 30 day share price return of 19.53%, alongside a 1 year total shareholder return of 26.32% that...